GENB Generate Biomedicines, Inc.: institutional ownership and insider trading
94 funds reported holding $1.72B of Generate Biomedicines, Inc. in their latest 13F filings; in Q2 2026 funds net bought $127M, with 42 new positions and 13 funds selling out; over the last 12 months insiders bought $150M and sold $16.0K on the open market.
Famous investors holding GENB
- Cathie Wood (ARK Investment Management): $21.7M, 0.1% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $669K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $370K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $310K, 0.0% of the portfolio
Largest institutional holders of GENB
- Flagship Pioneering Inc. — $1.06B
- FMR LLC — $88.1M
- Capital World Investors — $71.1M
- BRAIDWELL LP — $55.4M
- PRICE T ROWE ASSOCIATES INC /MD/ — $36.4M
- NORGES BANK — $35.3M
- ARCH Venture Management, LLC — $32.8M
- HARBOURVEST PARTNERS LLC — $29.1M
- BlackRock, Inc. (BLK) — $28.0M
- BANQUE PICTET & CIE SA — $26.6M
Recent GENB insider trades
- Sep 1, 2026: Arnold Frances sold 1,000 shares ($16.0K)
- Mar 4, 2026: Nally Michael bought 20,000 shares ($240K)
- Mar 2, 2026: Grous Beth bought 300 shares ($4.80K)
- Mar 2, 2026: Silvers Jason bought 2,000 shares ($32.0K)
5%+ owners
- Afeyan Noubar: 48.9% (Schedule 13G, filed May 15, 2026)
- Nally Michael: 5.2% (Schedule 13G, filed May 15, 2026)